Quest PharmaTech Inc. (QPTFF)
OTCMKTS
· Delayed Price · Currency is USD
0.0133
-0.0017 (-11.33%)
At close: Jul 15, 2024
Quest PharmaTech Income Statement
Financials in millions CAD. Fiscal year is February - January.
Millions CAD. Fiscal year is Feb - Jan.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 31, 2024 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 | Jan '21 Jan 31, 2021 | Jan '20 Jan 31, 2020 | 2015 - 2019 |
| Selling, General & Admin | 0.63 | 0.82 | 0.54 | 0.64 | 0.87 | 2.37 | Upgrade
|
| Research & Development | 0.26 | 0.5 | 0.3 | 0.15 | 0.2 | 11.26 | Upgrade
|
| Operating Expenses | 0.89 | 1.32 | 0.83 | 0.79 | 1.07 | 13.63 | Upgrade
|
| Operating Income | -0.89 | -1.32 | -0.83 | -0.79 | -1.07 | -13.63 | Upgrade
|
| Interest Expense | -0.03 | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Interest & Investment Income | - | - | - | - | 0 | 0.05 | Upgrade
|
| Earnings From Equity Investments | -0.66 | -0.52 | -3.1 | -57.75 | 164.17 | -0.03 | Upgrade
|
| Currency Exchange Gain (Loss) | -0 | -0 | -0 | -0 | 0 | 0.38 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.22 | 0.17 | 0.45 | 0.24 | 0.21 | - | Upgrade
|
| EBT Excluding Unusual Items | -1.37 | -1.68 | -3.5 | -58.32 | 163.31 | -13.25 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.72 | -1.34 | -61.39 | -26.72 | -101.56 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | 128.32 | - | Upgrade
|
| Pretax Income | -2.09 | -3.02 | -64.89 | -85.04 | 190.06 | -13.25 | Upgrade
|
| Earnings From Continuing Operations | -2.09 | -3.02 | -64.89 | -85.04 | 190.06 | -13.25 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | - | -0.02 | Upgrade
|
| Net Income to Company | -2.09 | -3.02 | -64.89 | -85.04 | 190.06 | -13.28 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | - | 7.09 | Upgrade
|
| Net Income | -2.09 | -3.02 | -64.89 | -85.04 | 190.06 | -6.18 | Upgrade
|
| Net Income to Common | -2.09 | -3.02 | -64.89 | -85.04 | 190.06 | -6.18 | Upgrade
|
| Shares Outstanding (Basic) | 169 | 169 | 168 | 168 | 168 | 167 | Upgrade
|
| Shares Outstanding (Diluted) | 169 | 169 | 168 | 168 | 171 | 167 | Upgrade
|
| Shares Change (YoY) | 0.27% | 0.44% | 0.09% | -1.57% | 2.10% | 0.13% | Upgrade
|
| EPS (Basic) | -0.01 | -0.02 | -0.39 | -0.51 | 1.13 | -0.04 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.02 | -0.39 | -0.51 | 1.11 | -0.04 | Upgrade
|
| Free Cash Flow | -0.59 | -0.34 | -0.55 | -0.17 | -2.52 | -6.38 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 | -0.04 | Upgrade
|
| EBITDA | -0.89 | -1.31 | -0.82 | -0.79 | -1.07 | -13.63 | Upgrade
|
| D&A For EBITDA | 0 | 0 | 0.01 | 0 | 0 | 0.01 | Upgrade
|
| EBIT | -0.89 | -1.32 | -0.83 | -0.79 | -1.07 | -13.63 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.